This is a Delivery Order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a component of the Department of Defense. The $3,521.34 firm fixed-price contract is for the pharmaceutical product Trelegy Ellipta, a combination medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of November 15, 2024.
Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other medical commodities. This Delivery Order appears to be a task order issued under that larger IDC vehicle. The contract does not have a set-aside designation, indicating open competition.
Generated 2/13/25, 9:03 AM